Penumbra, Inc. (PEN)
320.87
+1.47
(+0.46%)
USD |
NYSE |
Oct 12, 16:00
320.87
0.00 (0.00%)
After-Hours: 18:07
Penumbra Free Cash Flow (Quarterly) : 32.54M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.54M |
| March 31, 2026 | 73.30M |
| December 31, 2025 | 68.05M |
| September 30, 2025 | 42.01M |
| June 30, 2025 | 29.37M |
| March 31, 2025 | 35.50M |
| December 31, 2024 | 45.74M |
| September 30, 2024 | 51.02M |
| June 30, 2024 | 18.08M |
| March 31, 2024 | 32.47M |
| December 31, 2023 | 32.62M |
| September 30, 2023 | 27.51M |
| June 30, 2023 | 12.76M |
| March 31, 2023 | 9.235M |
| December 31, 2022 | -2.225M |
| September 30, 2022 | -19.26M |
| June 30, 2022 | -44.01M |
| March 31, 2022 | -9.471M |
| December 31, 2021 | -17.36M |
| September 30, 2021 | 30.65M |
| June 30, 2021 | -6.605M |
| March 31, 2021 | -18.36M |
| December 31, 2020 | -5.836M |
| September 30, 2020 | -7.703M |
| Date | Value |
|---|---|
| June 30, 2020 | -28.41M |
| March 31, 2020 | -16.05M |
| December 31, 2019 | -3.217M |
| September 30, 2019 | 14.13M |
| June 30, 2019 | -1.842M |
| March 31, 2019 | -4.531M |
| December 31, 2018 | 4.491M |
| September 30, 2018 | 8.987M |
| June 30, 2018 | -2.158M |
| March 31, 2018 | 7.885M |
| December 31, 2017 | -6.634M |
| September 30, 2017 | 6.813M |
| June 30, 2017 | -1.52M |
| March 31, 2017 | -1.00M |
| December 31, 2016 | -16.91M |
| September 30, 2016 | 2.349M |
| June 30, 2016 | -7.178M |
| March 31, 2016 | -4.699M |
| December 31, 2015 | -10.62M |
| September 30, 2015 | -5.734M |
| June 30, 2015 | -7.444M |
| March 31, 2015 | -3.96M |
| June 30, 2014 | 1.855M |
| March 31, 2014 | -0.681M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Boston Scientific Corp. | 1.279B |
| Teleflex, Inc. | 80.30M |
| Globus Medical, Inc. | 176.57M |
| Integra LifeSciences Holdings Corp. | 10.50M |
| Abbott Laboratories | 1.991B |